Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOl and etc.
Shigeyasu K, Toden S, Ozawa T, et al. The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer. Mol Cancer. 2020;19(1):155.
Zhao H, Liu X, Yu L, et al. Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in BC subtypes. Mol Ther Nucleic Acids. 2021;23:667-681.
Taylor TE, Furnari FB, Cavenee WK. Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance. Curr Cancer Drug Targets. 2012;12(3):197-209.
Chae Y, Roh J, Kim W. The roles played by long non-coding RNAs in glioma resistance. Int J Mol Sci. 2021;22(13):6834.
Zhao C, Wang Y, Tu F, et al. A prognostic autophagy-related long non-coding RNA (ARlncRNA) signature in acute myeloid leukemia (AML). Front Genet. 2021;12:681867.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).